Hainan Haiyao Co., Ltd.

Shenzhen Stock Exchange 000566.SZ

Hainan Haiyao Co., Ltd. Price to Earnings Ratio (P/E) on January 27, 2025: -51.28

Hainan Haiyao Co., Ltd. Price to Earnings Ratio (P/E) is -51.28 on January 27, 2025, a -4.80% change year over year. Price to earnings ratio compares the stock price to earnings per share; higher P/E suggests expectations for future earnings growth.

Hainan Haiyao Co., Ltd. 52-week high Price to Earnings Ratio (P/E) is -34.20 on July 24, 2024, which is 33.31% above the current Price to Earnings Ratio (P/E).
Hainan Haiyao Co., Ltd. 52-week low Price to Earnings Ratio (P/E) is -78.22 on November 07, 2024, which is -52.53% below the current Price to Earnings Ratio (P/E).
Hainan Haiyao Co., Ltd. average Price to Earnings Ratio (P/E) for the last 52 weeks is -47.27.

Key data

Date	Price to Earnings Ratio (P/E)	Price to Sales Ratio (P/S)	Price to Book Ratio (P/B)	Dividend Yield

Shenzhen Stock Exchange: 000566.SZ

Hainan Haiyao Co., Ltd.

CEO	Ms. Junhong Wang
IPO Date	May 25, 1994
Location	China
Headquarters	No. 192, Nanhai Avenue
Employees	2,108
Sector	Healthcare
Industries Pharmaceuticals 3D Printing Biotechnology Cosmetics Drugstores & Retail Pharmacies Personal Care Pet Food Plastics

Description

Hainan Haiyao Co., Ltd. manufactures and sells pharmaceutical products and medical devices in China and internationally. The company develops intermediates, APIs, innovative chemical drugs, modern Chinese medicines, biological drugs, cellular immunity products, and high-end medical devices. It offers its products in various forms, such as pills, tablet granules, tincture fluid extracts, powders, syrups, soft capsule raw materials, powder injections, and health foods in various antibiotic series, gastrointestinal medication series, anti-tumor medicine series, cochlear implant series, etc.; and vitamin C for injection scurvy, idiopathic methemoglobinemia, etc. The company also provides internet medical treatment and medical services. Hainan Haiyao Co., Ltd. was founded in 1965 and is headquartered in Haikou, China.

Key trends

Past 5 years